Multiplikator Forward P/S: Pulmonx Corp (LUNG)

Pulmonx - logo grafis emiten LUNG

Despite a heavy reliance on external equipment assemblers, Pulmonx Corporation remains resilient. The forward P/S metric reflects the current market valuation, with the value stabilizing at 1.40. Stability is driven by the recognized Zephyr systems and contracts with US clinics, while professional management effectively scales sales while maintaining strict control over operating expenses.

Pulmonx - Kapitalisasi marang prakiraan pendapatan LUNG (periode 04.07.2022 - 16.11.2026)

Ringkesan rincian data analitis Pulmonx (LUNG)

- rega pasar lan target rega analis:
Analisis fundamental perusahaan:LUNG (pulmonx.com)
Sampel barang pulmonx.com

To minimize fundamental risks, investors select assets with a stable ratio of market capitalization to projected revenue, which allows for an assessment of the premium paid for future growth. The trend of the expected P/S multiple reflects market confidence in the scaling of the Pulmonx Corporation clinic network, where a decrease in the indicator may signal an undervaluation of the expansion of innovative valves in the US market.

Karo sapa Pulmonx Corporation saingan

Rasio rega marang prakiraan pendapatan Dexcom CGM DXCM|Penumbra Corp (PEN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Novanta Inc - Multiplikator Forward P/S|HAE (Haemonetics Corporation) - Kapitalisasi marang prakiraan pendapatan|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED Inc.) - Multiplikator Forward P/S|Pulse Corp (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator Forward P/S picardmedical.com (PMI)|Multiplikator Forward P/S SRDX (surmodics.com)|Multiplikator Forward P/S Senseonics Holdings, Inc. SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (Sanuwave Health Inc) - Multiplikator forward rega marang pendapatan|Prakiraan rega marang pendapatan Outset Medical OM|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep LENSAR Inc. LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical Inc. (RCEL)|Profound Medical Corporation (PROF) - Prakiraan rega marang pendapatan|Baird Medical Investment Holdings - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP Medical EDAP|Apyx Medical Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical ICCM|TELA Bio (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corp.)|Rasio rega marang prakiraan pendapatan sensushealthcare.com|Multiplikator forward rega marang pendapatan Zynex, Inc. (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan inspira-technologies.com IINN|Rasio rega marang pendapatan sing dikarepake ICU (SeaStar Medical Holding Corp.)|IRIX: Multiplikator forward rega marang pendapatan|ibs.inc - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|Rega mangsa ngarep marang pendapatan PFSA (Profusa Inc.)|Multiplikator forward rega marang pendapatan SSKN|Rasio rega marang prakiraan pendapatan GCTK|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|Venus Concept - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S NUWE (Nuwellis Corp)|Rega forward marang dodolan AEMD|ASXC - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Avinger, Inc (AVGR)|BSGM: Multiplikator Forward P/S|Cutera (CUTR) - Multiplikator Forward P/S|KNW (Know Labs) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Inari Medical (NARI)|Rasio rega marang prakiraan pendapatan nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical)